Comment on “In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2”

Comment on “In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2”

No Abstract

Bibliographic Details
Main Authors:	Reza Gharebaghi, Fatemeh Heidary
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2022-05-01
Series:	Iranian Journal of Public Health
Online Access:	https://ijph.tums.ac.ir/index.php/ijph/article/view/28125

Similar Items

Response Comment on “In Silico Comparison of Separate or Combinatorial Effects of Potential Inhibitors of the SARS-CoV-2 Binding Site of ACE2”
by: Mostafa Shakhsi-Niaei, et al.
Published: (2022-05-01)

Effect of An 84-bp Deletion of the Receptor-Binding Domain on the ACE2 Binding Affinity of the SARS-CoV-2 Spike Protein: An In Silico Analysis
by: Gábor Kemenesi, et al.
Published: (2021-01-01)

Different In Silico Approaches Using Heterocyclic Derivatives against the Binding between Different Lineages of SARS-CoV-2 and ACE2
by: Federica Sipala, et al.
Published: (2023-05-01)

Mapping of ACE2 binding site on SARS-CoV-2 spike protein S1: docking study with peptides
by: Jaak Järv, et al.
Published: (2020-06-01)

Mapping the ACE2 binding site on the SARS-CoV-2 spike protein S1: molecular recognition pattern
by: Aleksei Kuznetsov, et al.
Published: (2020-10-01)

Structural analysis of a simplified model reproducing SARS-CoV-2 S RBD/ACE2 binding site
by: Michela Buonocore, et al.
Published: (2022-11-01)

COVO-CHAT: An Innovative Telemedicine Tool for Infodemic Management and Online Consultation during the COVID-19 Pandemic
by: Fatemeh Heidary, et al.
Published: (2022-10-01)

COVID-19 and Iran: swimming with hands tied!
by: Reza Gharebaghi, et al.
Published: (2020-04-01)

Prevalence of Visual Impairment in School Children
by: Reza Gharebaghi, et al.
Published: (2020-02-01)

Does SARS-CoV-2 bind to human ACE2 stronger than SARS-CoV?
by: Nguyen, HL, et al.
Published: (2020)

Exploring the disruption of SARS-CoV-2 RBD binding to hACE2
by: Camryn Carter, et al.
Published: (2023-10-01)

<i>In silico</i> screening of chalcones and their derivatives as potential inhibitors of spike proteins and ACE2 enzymes for SARS-CoV-2 treatment
by: Thi Thu Hang Ta, et al.
Published: (2022-06-01)

A novel inhibitor of SARS-CoV infection: Lactulose octasulfate interferes with ACE2-Spike protein binding
by: Rami Adel Pashameah, et al.
Published: (2024-01-01)

Identification of hACE2-interacting sites in SARS-CoV-2 spike receptor binding domain for antiviral drugs screening
by: Xiaopeng Hu, et al.
Published: (2022-11-01)

A Competitive Panning Method Reveals an Anti-SARS-CoV-2 Nanobody Specific for an RBD-ACE2 Binding Site
by: Siqi He, et al.
Published: (2023-02-01)

The specific applications of the TSR-based method in identifying Zn2+ binding sites of proteases and ACE/ACE2
by: Titli Sarkar, et al.
Published: (2022-12-01)

Theoretical Investigation of the Green-Synthesized Carbon-Based Nanomaterial Potential as Inhibitors of ACE2 for Blocking SARS-CoV‑2 Binding
by: Harsiwi Candra Sari, et al.
Published: (2024-03-01)

The Development of Pharmacophore Models for the Search of New Natural Inhibitors of SARS-CoV-2 Spike RBD–ACE2 Binding Interface
by: Valentin A. Semenov, et al.
Published: (2022-12-01)

Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor
by: Linda Jansen-Olliges, et al.
Published: (2022-12-01)

Design and Identification of Inhibitors for the Spike-ACE2 Target of SARS-CoV-2
by: Ruan S. Bastos, et al.
Published: (2023-05-01)

Synthetic carbohydrate-binding agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2
by: Oscar Francesconi, et al.
Published: (2022-05-01)

Arthropod Ectoparasites Have Potential to Bind SARS-CoV-2 via ACE
by: Su Datt Lam, et al.
Published: (2021-04-01)

Rapid screening of SARS-CoV-2 inhibitors via ratiometric fluorescence of RBD–ACE2 complexes in living cells by competitive binding
by: Lu Miao, et al.
Published: (2022-09-01)

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
by: Huo, J, et al.
Published: (2020)

Single-Molecule Investigation of the Binding Interface Stability of SARS-CoV‑2 Variants with ACE2
by: Ankita Ray, et al.
Published: (2024-03-01)

Evolution of SARS-CoV-2 Spikes shapes their binding affinities to animal ACE2 orthologs
by: Weitong Yao, et al.
Published: (2023-12-01)

CEBIT screening for inhibitors of the interaction between SARS-CoV-2 spike and ACE2
by: Gaofeng Pei, et al.
Published: (2022-07-01)

Mechanistic Origin of Different Binding Affinities of SARS-CoV and SARS-CoV-2 Spike RBDs to Human ACE2
by: Zhi-Bi Zhang, et al.
Published: (2022-04-01)

The pH Effects on SARS-CoV and SARS-CoV-2 Spike Proteins in the Process of Binding to hACE2
by: Yixin Xie, et al.
Published: (2022-02-01)

In-silico study for the identification of potential destabilizers between the spike protein of SARS-CoV-2 and human ACE-2
by: Jeffry Medina-Barandica, et al.
Published: (2023-01-01)

In Vitro Evaluation of In Silico Screening Approaches in Search for Selective ACE2 Binding Chemical Probes
by: Alexey V. Rayevsky, et al.
Published: (2022-08-01)

Decoy peptides effectively inhibit the binding of SARS-CoV-2 to ACE2 on oral epithelial cells
by: Lai-Keng Loi, et al.
Published: (2023-12-01)

Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding
by: Abdullah Hoter, et al.
Published: (2022-05-01)

Peptide foldamer-based inhibitors of the SARS-CoV-2 S protein–human ACE2 interaction
by: Violeta Marković, et al.
Published: (2023-12-01)

Different aspects in explaining how mutations could affect the binding mechanism of receptor binding domain of SARS-CoV-2 spike protein in interaction with ACE2.
by: Farzaneh Jafary, et al.
Published: (2023-01-01)

The Increased Amyloidogenicity of Spike RBD and pH-Dependent Binding to ACE2 May Contribute to the Transmissibility and Pathogenic Properties of SARS-CoV-2 Omicron as Suggested by In Silico Study
by: Anna Y. Aksenova, et al.
Published: (2022-11-01)

Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions
by: Xiaofeng Liu, et al.
Published: (2023-01-01)

SARS-CoV-2 Binding and Neutralization Properties of Peptides Derived from N-Terminus of Human ACE2
by: Irina V. Astrakhantseva, et al.
Published: (2023-05-01)

Lactoferrin Inhibition of the Complex Formation between ACE2 Receptor and SARS CoV-2 Recognition Binding Domain
by: Roberta Piacentini, et al.
Published: (2022-05-01)

A Pathway Model to Understand the Evolution of Spike Protein Binding to ACE2 in SARS-CoV-2 Variants
by: Ludovico Pipitò, et al.
Published: (2022-10-01)